$2.03
0.021.00%
After Hours: 6:59 PM EDT
15 minutes delayed
Comments
Loading...
Metagenomi (NASDAQ:MGX) Stock Quotes, Forecast and News Summary
Metagenomi Stock (NASDAQ: MGX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Metagenomi (MGX) stock?
You can purchase shares of Metagenomi (NASDAQ:MGX) through any online brokerage.
Who are Metagenomi (MGX) competitors?
Other companies in Metagenomi’s space includes: Cellectar Biosciences (NASDAQ:CLRB), Connect Biopharma Hldgs (NASDAQ:CNTB), Immuneering (NASDAQ:IMRX), Citius Oncology (NASDAQ:CTOR) and Vistagen Therapeutics (NASDAQ:VTGN).
What is the forecast, or price target, for Metagenomi (MGX) stock?
Metagenomi has a consensus price target of $15.50.
What is the current price for Metagenomi (MGX)?
The stock price for Metagenomi (NASDAQ: MGX) is $1.955 last updated October 9, 2024 at 3:55 PM EDT.
Does Metagenomi (MGX) pay a dividend?
There are no upcoming dividends for Metagenomi.
When is Metagenomi (NASDAQ:MGX) reporting earnings?
Metagenomi’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is Metagenomi (MGX) going to split?
There is no upcoming split for Metagenomi.
What sector and industry does Metagenomi (MGX) operate in?
Metagenomi is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.